# Lenalidomide in Older Patients With Acute Myeloid Leukemia Without Chromosome 5q Abnormalities

> **NCT00546897** · PHASE2 · COMPLETED · sponsor: **Washington University School of Medicine** · enrollment: 48 (actual)

## Conditions studied

- Leukemia, Myeloid, Acute

## Interventions

- **DRUG:** Lenalidomide

## Key facts

- **NCT ID:** NCT00546897
- **Lead sponsor:** Washington University School of Medicine
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-02
- **Primary completion:** 2010-06
- **Final completion:** 2012-03
- **Target enrollment:** 48 (ACTUAL)
- **Last updated:** 2014-09-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00546897

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00546897, "Lenalidomide in Older Patients With Acute Myeloid Leukemia Without Chromosome 5q Abnormalities". Retrieved via AI Analytics 2026-08-12 from https://api.ai-analytics.org/clinical/NCT00546897. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*